ABSTRACT
Objective: To explore the entry points and monitoring points of individualized treatment for fracture surgery patients with ARDS.Methods: Clinical pharmacists comprehensively assessed the patient's conditions and looked up lots of literatures.Some suggestions on the anti-infection treatment efforts, glucocorticoid use dispute and rational use of ambroxol were offered.The efficacy and adverse reactions of drugs in the treatment process were monitored using some subjective and objective indicators.Results: The consensus about the pros and cons, dosages, as well as the possible dosage decrease of glucocorticoid therapy, the dosages of antimicrobial agents, and the dosages and treatment course of ambroxol was achieved between clinical pharmacists and doctors.As a result, the maximum benefits were obtained for the patient.Conclusion: Clinical pharmacists can explore the treatment and monitoring for specific diseases and find out intervention entry points of clinicians and patients to play a certain role in clinics, and accumulate treatment experience gradually.
ABSTRACT
Objective:To find out the general regularity of antibiotic encephalopathy caused by cefepime through the case analy -sis, and give reasonable suggestions according to the clinical features .Methods: According to the patient's conditions , the clinical pharmacist consulted a large number of literatures and excluded the other factors such as the clinical manifestation of the patient and the used drugs.The clinical pharmacist analyzed the possibility of drug-induced nervous system damage in the aspects of the administration time, dose, drug interactions and changes of symptoms and signs after the drug withdrawal .Results:The clinical pharmacist performed the rational analysis and judgment , provided suggestions for the doctors , and terminated the nervous system damage caused by cefepime in time.Conclusion:In clinical practice , clinical pharmacists analyze drug therapy events and provide pharmaceutical care , which is beneficial to safe and rational drug use .
ABSTRACT
Objective To analyze whether routine prophyrlactic antibiotic administration is necessary for the patients undergoing coronary stent implantation. Methods The clinical data of 156 patients from January 2010 to December 2010 (prophylactic antibiotic therapy),and 466 patients from January 2014 to December 2014(no-prophylactic antibiotic therapy), who underwent coronary stent implantation, were retrospectively analyzed. The prophylactic antibiotics and the infection rates in two groups were compared. Results The rate of infections related to coronary stent implantation in no-prophylactic antibiotic therapy group and prophylactic antibiotic therapy group, such as surgical site infection (0.2% vs 1.3%,P>0.05) and catheter-related infection(0.6% vs 1.9%,P>0.05), was not significant different(P>0.05). Similarly, the unrelated to coronary stent implantation was not significant different, too ( P > 0. 05). Conclusion Routine prophylactic antibiotic administration is unnecessary for the patients undergoing coronary stent implantation.